< Annex IV: Montreal Declaration Up one level Decision XVIII/1: Membership of the Implementation Committee > Eighteenth Meeting of the Parties Decision XVIII/1: Membership of the Implementation Committee Decision XVIII/2: Membership of the Executive Committee of the Multilateral Fund for the Implementation of the Montreal Protocol Decision XVIII/3: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol Decision XVIII/4: Co-chair of the Chemicals Technical Options Committee Decision XVIII/5: Financial matters: financial reports and budgets Decision XVIII/6: Ratification of the Vienna Convention, the Montreal Protocol and the London, Copenhagen, Montreal and Beijing amendments to the Protocol Decision XVIII/7: Essential-use exemptions for Parties for controlled substances for 2007 and 2008 Decision XVIII/8: Essential-use exemption for chlorofluorocarbon-113 for aerospace applications in the Russian Federation for 2007 Decision XVIII/9: Review of draft terms of reference for case studies called for under decision XVII/17 on environmentally sound destruction of ozone-depleting substances Decision XVIII/10: Sources of carbon tetrachloride emissions and opportunities for reductions Decision XVIII/11: Sources of n-propyl bromide emissions, alternatives available and opportunities for reductions Decision XVIII/12: Future work following the Ozone Secretariat workshop on the Intergovernmental Panel on Climate Change/Technology and Economic Assessment Panel special report Decision XVIII/13: Critical-use exemptions for methyl bromide for 2007 and 2008 Decision XVIII/14: Montreal Protocol/International Plant Protection Convention cooperation on the use of alternatives to methyl bromide for quarantine and preshipment Decision XVIII/15: Laboratory and analytical critical uses of methyl bromide Decision XVIII/16: Difficulties faced by some Article 5 Parties manufacturing metered-dose inhalers which use chlorofluorocarbons Decision XVIII/17: Treatment of stockpiled ozone-depleting substances relative to compliance Decision XVIII/18: Preventing illegal trade in ozone-depleting substances through systems for monitoring their transboundary movement between Parties Decision XVIII/19: Guidelines for disclosure of interest for groups such as the Technology and Economic Assessment Panel and its technical options committees Decision XVIII/20: Non-compliance with the Montreal Protocol by Armenia Decision XVIII/21: Non-compliance in 2005 with the control measures of the Montreal Protocol governing consumption of the controlled substances in Annex B, group II, (carbon tetrachloride) and Annex B, group III, (methyl chloroform) by the Democratic Republic of the Congo Decision XVIII/22: Non-compliance in 2005 with the control measures of the Montreal Protocol governing consumption of the controlled substances in Annex A, group I, (CFCs) by Dominica Decision XVIII/23: Non-compliance in 2005 with the control measures of the Montreal Protocol governing consumption of the controlled substance in Annex E (methyl bromide) by Ecuador and request for a plan of action Decision XVIII/24: Potential non-compliance in 2005 with the control measures of the Montreal Protocol governing consumption of the controlled substances in Annex A, group I, (CFCs) by Eritrea and request for a plan of action Decision XVIII/25: Non-compliance with regard to the transfer of CFC production rights by Greece Decision XVIII/26: Revised plan of action to return Guatemala to compliance with the control measures in Article 2H of the Montreal Protocol Decision XVIII/27: Potential non-compliance in 2005 with the control measures of the Montreal Protocol governing consumption of the controlled substance in Annex B group II, (carbon tetrachloride) by the Islamic Republic of Iran and request for a plan of action Decision XVIII/28: Non-compliance with the Montreal Protocol by Kenya Decision XVIII/29: Request for change in baseline data by Mexico Decision XVIII/30: Non-compliance in 2005 with the control measures of the Montreal Protocol governing consumption of the controlled substance in Annex B, group II, (carbon tetrachloride) by Mexico Decision XVIII/31: Non-compliance with the Montreal Protocol by Pakistan Decision XVIII/32: Non-compliance in 2005 with the control measures of the Montreal Protocol governing consumption of the controlled substances in Annex A, group I, (CFCs) and Annex B, group II, (carbon tetrachloride) by Paraguay and request for a plan of action Decision XVIII/33: Non-compliance with data-reporting requirements for the purpose of establishing baselines under paragraphs 3 and 8 ter (d) of Article 5 by Serbia Decision XVIII/34: Data and information provided by the Parties in accordance with Article 7 of the Montreal Protocol Decision XVIII/35: Report on the establishment of licensing systems under Article 4B of the Montreal Protocol Decision XVIII/36: Dialogue on key future challenges to be faced by the Montreal Protocol Decision XVIII/37: Nineteenth Meeting of the Parties to the Montreal Protocol Annex I: Trust Fund for the Montreal Protocol on Substances that Deplete the Ozone Layer: approved 2006, 2007 and 2008 budgets Annex II: Trust Fund for the Montreal Protocol on Substances that Deplete the Ozone Layer: scale of contributions by the Parties for the years 2007 and 2008 Annex III: Essential-use authorizations for 2007 and 2008 of chlorofluorocarbons for metered-dose inhalers approved by the Eighteenth Meeting of the Parties < Annex IV: Montreal Declaration Up one level Decision XVIII/1: Membership of the Implementation Committee >
